Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Bruker (BRKR)

Bruker Appoints Laura Francis to Board, Expanding It to Ten Directors

Neutral Impact 2 of 5 leadership Written later

Bruker Corporation's Board increased its size by one seat to ten directors and appointed Laura Francis, CEO of SI-BONE, Inc., to fill the new vacancy effective February 18, 2025. The filing says she will join the Audit Committee after the 2025 annual meeting and that her director pay will match other non-employee directors.

Key points

  • Laura Francis appointed director effective February 18, 2025, serving until the 2026 Annual Meeting of Stockholders
  • Board expanded from nine to ten directors, with the new seat assigned to Class II
  • Francis expected to join the Audit Committee as a financial expert after the end of May 2025 annual meeting
  • Francis is CEO and a board member of SI-BONE, Inc. (Nasdaq: SIBN) and previously served as Bruker's CFO-era executive in an earlier career

The filing

CompanyBruker (BRKR)
Form8-K, current report
Filed with the SECFeb 21, 2025, 8:00 AM ET
Accession number0000950170-25-024543

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.